CARSEP XII
Question 349
0
A 53-year-old man with rectal cancer starting at 2 cm from anorectal ring presents to the office to discuss further management. He has undergone chemoradiation and consolidation FOLFOX chemotherapy for cT3N1aM0 microsatellite proficient tumor. He has a partial response with a residual palpable mass. He normally has up to five bowel movements per day with urgency and fecal leakage. What is the best next surgical treatment for him?
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Question 349." CARSEP XII, ASCRS U, www.ascrsu.com/ascrs/view/CARSEP XII/3094349/all/Malignancy. Accessed 04 April 2026.
Question 349. CARSEP XII. https://www.ascrsu.com/ascrs/view/CARSEP XII/3094349/all/Malignancy. Accessed April 4, 2026.
Question 349. In CARSEP XII https://www.ascrsu.com/ascrs/view/CARSEP XII/3094349/all/Malignancy
Question 349 [Internet]. In: CARSEP XII. [cited 2026 April 04]. Available from: https://www.ascrsu.com/ascrs/view/CARSEP XII/3094349/all/Malignancy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Question 349
ID - 3094349
BT - CARSEP XII
UR - https://www.ascrsu.com/ascrs/view/CARSEP XII/3094349/all/Malignancy
DB - ASCRS U
DP - Unbound Medicine
ER -
